(Q48240145)

9 February 2018

title

S100B and response to treatment in major depression: a pilot study (English)

1 reference

9 February 2018

author

Andreas Erfurth

3

1 reference

9 February 2018

Volker Arolt

1

object named as

Volker Arolt

1 reference

9 February 2018

Martin Wiesmann

4

object named as

Martin Wiesmann

1 reference

9 February 2018

author name string

Marion Peters

2

1 reference

9 February 2018

Ulrich Missler

5

1 reference

9 February 2018

Sebastian Rudolf

6

1 reference

9 February 2018

Holger Kirchner

7

1 reference

9 February 2018

Matthias Rothermundt

8

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 August 2003

1 reference

9 February 2018

European Neuropsychopharmacology

published in

1 reference

9 February 2018

volume

13

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

235-239

1 reference

9 February 2018

Serotonin may stimulate granule cell proliferation in the adult hippocampus, as observed in rats grafted with foetal raphe neurons

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Neural plasticity to stress and antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Synaptic plasticity and mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Potential involvement of S100B in the protective effects of a serotonin-1a agonist on ethanol-treated astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Effects of ethanol and 5-HT1A agonists on astroglial S100B.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Neurotrophic factor S100 beta in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Plasma norepinephrine and prediction of outcome in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Increased serum S100B protein in schizophrenia: a study in medication-free patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Repeated electroconvulsive shock promotes the sprouting of serotonergic axons in the lesioned rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Trophic interactions between brain-derived neurotrophic factor and s100beta on cultured serotonergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Normal development of serotonergic neurons in mice lacking S100B.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Dynamics of brain-derived proteins in cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

The DST as a predictor of outcome in depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

S100B in brain damage and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

S-100B is increased in melancholic but not in non-melancholic major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Three- to 5-year prospective follow-up of outcome in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Elevated plasma levels of S-100b protein in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900016-6

7 January 2021

10.1016/S0924-977X(03)00016-6

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018